Cas:83585-56-2 1,4,7,10,13-pentaoxacyclopentadec-2-ylmethanamine manufacturer & supplier

Chemical Name:1,4,7,10,13-pentaoxacyclopentadec-2-ylmethanamine

CAS.NO:83585-56-2

Synonyms:1,4,7,10,13-Pentaoxacyclopentadecane-2-methanamine;MFCD00191740;2-Aminomethyl-15-crown-5;2-AMINOMETHYL-15-CROWN-5 PURUM

Molecular Formula:C₁₁H₂₃NO₅

Molecular Weight:249.30400

HS Code:2932999099

Physical and Chemical Properties:

Melting point:N/A

Boiling point:115ºC0.08 mm Hg(lit.)

Density:1.134 g/mL at 25ºC(lit.)

Index of Refraction:n20/D 1.48(lit.)

PSA:72.17000

Exact Mass:249.15800

LogP:0.11060

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1,4,7,10,13-Pentaoxacyclopentadecane-2-methanamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-AMINOMETHYL-15-CROWN-5 PURUM physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00191740 Use and application,2-Aminomethyl-15-crown-5 technical grade,usp/ep/jp grade.

Related News: One source familiar with the matter told Reuters that the J&J doses are expected to be exported to other countries. The doses are already in vials and ready for use, the other source said. 1,4,7,10,13-pentaoxacyclopentadec-2-ylmethanamine manufacturer With the onset of the DMF system for APIs, the concentration of the API industry will further increase. 1,4,7,10,13-pentaoxacyclopentadec-2-ylmethanamine supplier The Breakthrough Designation for the iLet Bionic Pancreas System contemplates configurations with most insulin analogs approved for pumping as well as dasiglucagon, Zealand Pharma��s stable pumpable glucagon analog, which has a unique stability profile in a ready-to-use aqueous solution. 1,4,7,10,13-pentaoxacyclopentadec-2-ylmethanamine vendor Zhejiang Huahai Pharmaceutical: It is a leading company in domestic APIs, especially in the field of cardiovascular drugs. 1,4,7,10,13-pentaoxacyclopentadec-2-ylmethanamine factory One source familiar with the matter told Reuters that the J&J doses are expected to be exported to other countries. The doses are already in vials and ready for use, the other source said.